Pharmacokinetic Drug Interactions of Antimicrobial Drugs: A Systematic Review on Oxazolidinones, Rifamycines, Macrolides, Fluoroquinolones, and Beta-Lactams

Pharmacokinetic Drug Interactions of Antimicrobial Drugs: A Systematic Review on Oxazolidinones, Rifamycines, Macrolides, Fluoroquinolones, and Beta-Lactams

Like any other drug, antimicrobial drugs are prone to pharmacokinetic drug interactions. These drug interactions are a major concern in clinical practice as they may have an effect on efficacy and toxicity. This article provides an overview of all published pharmacokinetic studies on drug interactio...

Full description

Bibliographic Details
Main Authors:	Jan-Willem C. Alffenaar, Arianna D. Pranger, Mathieu S. Bolhuis, Jos G. W. Kosterink, Prashant N. Panday
Format:	Article
Language:	English
Published:	MDPI AG 2011-11-01
Series:	Pharmaceutics
Subjects:	pharmacokinetics drug interaction antimicrobial drugs oxazolidinones rifamycines macrolides fluoroquinolones beta-lactams cytochrome P450 induction inhibition
Online Access:	http://www.mdpi.com/1999-4923/3/4/865/

Similar Items

Investigational and Experimental Drugs for Community-Acquired Pneumonia: the Current Evidence
by: Sellarès-Nadal J, et al.
Published: (2020-11-01)

Respiratory Fluoroquinolones Monotherapy vs. β-Lactams With or Without Macrolides for Hospitalized Community-Acquired Pneumonia Patients: A Meta-Analysis
by: Sitong Liu, et al.
Published: (2019-05-01)

Synergistic anti-Campylobacter jejuni activity of fluoroquinolone and macrolide antibiotics with phenolic compounds
by: Euna eOh, et al.
Published: (2015-10-01)

Effect of Genetic Variations in Drug-Metabolizing Enzymes and Drug Transporters on the Pharmacokinetics of Rifamycins: A Systematic Review
by: Sileshi T, et al.
Published: (2022-06-01)

Long-Term Use of Tedizolid in Osteoarticular Infections: Benefits among Oxazolidinone Drugs
by: Eva Benavent, et al.
Published: (2021-01-01)

Detection and Prevalence of Macrolide and Fluoroquinolone Resistance in <i>Mycoplasma genitalium</i> in Badalona, Spain
by: Belén Rivaya, et al.
Published: (2022-04-01)

Efficacy of tetracyclines and fluoroquinolones for the treatment of macrolide-refractory Mycoplasma pneumoniae pneumonia in children: a systematic review and meta-analysis
by: Jong Gyun Ahn, et al.
Published: (2021-09-01)

Serotype distribution and resistance genes associated with macrolide and fluoroquinolone resistance in Streptococcus agalactiae isolates from a hospital in southern Taiwan
by: Ying-Hsiang Wang, et al.
Published: (2015-06-01)

The effect of therapeutic drug monitoring of beta-lactam and fluoroquinolones on clinical outcome in critically ill patients: the DOLPHIN trial protocol of a multi-centre randomised controlled trial
by: A. Abdulla, et al.
Published: (2020-01-01)

Synergistic Activity of Nitroimidazole-Oxazolidinone Conjugates against Anaerobic Bacteria
by: Zhijun Zhuang, et al.
Published: (2020-05-01)

Influence of Rifamycin on Survival in Patients with Concomitant Lung Cancer and Pulmonary Tuberculosis
by: Ho-Sheng Lee, et al.
Published: (2023-11-01)

Macrolide and fluoroquinolone resistance-associated mutations in Mycoplasma genitalium in Johannesburg, South Africa, 2007–2014
by: Etienne E. Muller, et al.
Published: (2019-02-01)

Detection of resistance to macrolides and fluoroquinolones in Mycoplasma genitalium by targeted next-generation sequencing
by: Calin B. Chiribau, et al.
Published: (2024-03-01)

Contezolid, a novel oxazolidinone antibiotic, may improve drug-related thrombocytopenia in clinical antibacterial treatment
by: Bi Li, et al.
Published: (2023-04-01)

Characterization of the Rifamycin-Degrading Monooxygenase From Rifamycin Producers Implicating Its Involvement in Saliniketal Biosynthesis
by: Xiao-Fu Zheng, et al.
Published: (2020-06-01)

Intralesional 8.33% Rifamycin infiltration; New treatment for cutaneous leishmaniasis
by: Nameer K. Al-Sudany, et al.
Published: (2016-01-01)

Cardiac events after macrolides or fluoroquinolones in patients hospitalized for community-acquired pneumonia: post-hoc analysis of a cluster-randomized trial
by: Douwe F. Postma, et al.
Published: (2019-01-01)

Rifamycin O, An Alternative Anti-<i>Mycobacterium abscessus</i> Agent
by: Bui Thi Bich Hanh, et al.
Published: (2020-03-01)

Macrolide Treatment Failure due to Drug–Drug Interactions: Real-World Evidence to Evaluate a Pharmacological Hypothesis
by: Brian Cicali, et al.
Published: (2022-03-01)

Genetic Determinants of Macrolide and Fluoroquinolone Resistance in <i>Mycoplasma genitalium</i> and Their Prevalence in Moscow, Russia
by: Inna Alexandrovna Edelstein, et al.
Published: (2023-03-01)

State of the Art on Developments of (Bio)Sensors and Analytical Methods for Rifamycin Antibiotics Determination
by: Hassan Noor, et al.
Published: (2023-01-01)

Structure-Antibacterial Activity Relationships of N-Substituted-(d-/l-Alaninyl) 1H-1,2,3-Triazolylmethyl Oxazolidinones
by: Oludotun Adebayo Phillips, et al.
Published: (2018-09-01)

8-Deoxy-Rifamycin Derivatives from <i>Amycolatopsis mediterranei</i> S699 <i>ΔrifT</i> Strain
by: Feng Ye, et al.
Published: (2020-09-01)

Evidence Associated with the Use of Oxazolidinones in the Treatment of Skin and Skin Structure Infections: A Retrospective Study
by: Tiago Santos, et al.
Published: (2020-02-01)

Evidence Associated with the Use of Oxazolidinones for the Treatment of Skin and Skin Structure Infections: A Retrospective Study
by: João Gonçalves-Pereira, et al.
Published: (2019-06-01)

Beta-Lactam vs. Fluoroquinolone Monotherapy for <i>Pseudomonas aeruginosa</i> Infection: A Systematic Review and Meta-Analysis
by: Eric Reid, et al.
Published: (2021-12-01)

Revisiting Oral Fluoroquinolone and Multivalent Cation Drug-Drug Interactions: Are They Still Relevant?
by: Stuart K. Pitman, et al.
Published: (2019-07-01)

Macrolide and fluoroquinolone associated mutations in Mycoplasma genitalium in a retrospective study of male and female patients seeking care at a STI Clinic in Guangzhou, China, 2016-2018
by: Wujian Ke, et al.
Published: (2020-12-01)

GROUP B AND G BETA-HEMOLYTIC STREPTOCOCCI IN POMURJE REGION – CHARACTERISTICS OF ANTIMICROBIAL RESISTANT ISOLATES
by: Iztok Štrumbelj, et al.
Published: (2003-05-01)

Empirical antibiotic treatment strategies for community-acquired pneumonia: a network meta-analysis
by: Lu-Yan Xu, et al.
Published: (2022-09-01)

A Novel Synthesis of the Oxazolidinone Antithrombotic Agent Rivaroxaban
by: Jianyong Yuan, et al.
Published: (2014-09-01)

How Combined Macrolide Nanomaterials are Effective Against Resistant Pathogens? A Comprehensive Review of the Literature
by: Siraj EA, et al.
Published: (2023-09-01)

Enhancing activity of β-lactam and fluoroquinolones antibiotics by artemisinin and its derivatives against MDR Escherichia coli
by: Shahbaz Ul Haq, et al.
Published: (2022-11-01)

Warfarin and Antibiotics: Drug Interactions and Clinical Considerations
by: Alexis J. Vega, et al.
Published: (2023-07-01)

Bioactive 7-Oxabicyclic[6.3.0]lactam and 12-Membered Macrolides from a Gorgonian-Derived Cladosporium sp. Fungus
by: Fei Cao, et al.
Published: (2015-07-01)

Synthesis and Characterization of Novel Oxazolidinones Via Schiff Base Reactions
by: Obaid H.Abid, et al.
Published: (2013-11-01)

Characterization of oxazolidinone and phenicol resistance genes in non-clinical enterococcal isolates from Korea
by: Young-Hee Jung, et al.
Published: (2021-03-01)

Adverse drug reactions of macrolide therapy: analysis of spontaneous reports according to the Pharmacovigilance system
by: Skryabina A.A., et al.
Published: (2023-03-01)

Scaling up for the industrial production of rifamycin B; optimization of the process conditions in bench-scale fermentor
by: Hewaida F. El-Sedawy, et al.
Published: (2013-06-01)

A feedback regulatory model for RifQ-mediated repression of rifamycin export in Amycolatopsis mediterranei
by: Chao Lei, et al.
Published: (2018-01-01)